SURVODUTIDE

A sophisticated dual agonist peptide designed to stimulate both GLP-1 and glucagon receptors, facilitating the synchronized regulation of satiety and metabolic rate. Optimized for superior stability and binding capacity, this molecule represents a crucial asset for advanced research into metabolic signaling.

Molecular Specifications

Type: Synthetic dual agonist peptide (GLP-1 / Glucagon)
Length: ~39 amino acids (engineered analog)
Molecular Weight: ~4.2–4.5 kDa
Structure: Modified incretin–glucagon hybrid sequence
Key Features: DPP-4 resistance, enhanced receptor affinity, extended activity profile
Solubility: Water-soluble
Charge Profile: pH-dependent
Stability: Sensitive to heat, light, and oxidation

COA

RESEARCH USE ONLY (RUO): THIS COMPOUND IS FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, VETERINARY, OR DIAGNOSTIC PURPOSES.